DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Nepicastat is an investigational drug.
There have been 4 clinical trials for Nepicastat. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Stress Disorders, Traumatic, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Biotie Therapies Inc., National Institute on Drug Abuse (NIDA), and Ralph H. Johnson VA Medical Center.
Recent Clinical Trials for Nepicastat
|A Multi-Center Trial of Nepicastat for Cocaine Dependence||National Institute on Drug Abuse (NIDA)||Phase 2|
|Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans||Baylor College of Medicine||Phase 2|
|Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans||Biotie Therapies Inc.||Phase 2|